Infection with the dengue virus is currently clinically detected according to different biomarkers in human blood plasma, commonly measured by enzyme linked immunosorbent assays, including non-structural proteins (Ns1), immunoglobulin M (IgM) and immunoglobulin G (IgG). However, there is little or no mutual correlation between the biomarkers, as demonstrated in this study by a comparison of their levels in samples from 17 patients. As an alternative, the label free, rapid screening technique, Raman spectroscopy has been used for the characterisation/diagnosis of healthy and dengue infected human blood plasma samples. In dengue positive samples, changes in specific Raman spectral bands associated with lipidic and amino acid/protein content are observed and assigned based on literature and these features can be considered as markers associated with dengue development. Based on the spectroscopic analysis of the current, albeit limited, cohort of samples, Principal Components Analysis (PCA) coupled Factorial Discriminant Analysis, yielded values of 97.95% sensitivity and 95.40% specificity for identification of dengue infection. Furthermore, in a comparison of the normal samples to the patient samples which scored low for only one of the biomarker tests, but high or medium for either or both of the other two, PCA-FDA demonstrated a sensitivity of 97.38 % and specificity of 86.18 %, thus providing an unambiguous screening technology.
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Introduction
Dengue disease has become a serious health concern, affecting millions of people worldwide every
year. According to the WHO [1] , about 3.97 billion people live in dengue pandemic tropical areas, and annually 400 million are infected, 96 million present clinically and 20,000 die of the disease.
In Pakistan, 539 deaths having been reported in the last 12 years, 55,946 persons were found to be infected and 60% of cases are thought not to be reported. Dengue is a mosquito bite infection transmitted by one of the four dengue virus serotypes [2] . It is spreading more quickly in urban and semi urban areas and has become a serious health problem [3] . In some cases, the disease develops into severe DSS (dengue shock syndrome) or DHF (dengue hemorrhagic fever), resulting in bleeding leading to thrombocytopenia, loss of blood plasma, and severely low blood pressure.
Children (≤15 years) are more severely infected than adults by dengue in Asia [3] [4] [5] [6] .
Dengue viruses contain a single strand of RNA of flavivirus [7] and produce new viral strands, translated and duplicated after infection. The non-structural proteins (Ns1) in the flavivirus regulate the duplication procedure of viral RNA [8] . The Ns1 proteins circulate in the blood plasma of dengue infected patients after the onset of symptoms of dengue fever for the first few days [9] and hence can be considered a viable biomarker for the diagnosis of disease by PCR (polymerase chain reaction) and ELISA (enzyme linked immunosorbent assay) in the early stage of infection [10] [11] .
Acute dengue infection can be confirmed by the presence of IgM (immunoglobulin M), while secondary dengue virus infection is indicated by the presence of IgG (immunoglobulin G) and both are also monitored by ELISA. Notably, the presence of IgM in a sample can indicate early stage infection, whereas the presence of elevated IgG levels, with normal IgM values, leads to the conclusion that dengue infection has occurred in the past [12] .
In the early stages, a comprehensive analysis of dengue infection or biochemical changes produced by the dengue virus is of significant value for the diagnosis of dengue and its prevention. Although the treatment of dengue is only symptomatic, because there is no specific cure available for it [13] , efficient and accurate diagnosis of the disease is important for clinical care which includes early detection of severe cases, case confirmation as well as differential diagnosis with other infectious diseases. Moreover, early diagnosis may also be required for outbreak control, pathogenesis, academic research, vaccine development, and clinical trials [14] . There are many diagnostic methods already used in clinical practice, based on the detection of RNA, antibodies in serological tests and virus isolation in cell culture etc. [15] [16] . The most common clinically employed diagnostic methods for dengue detection are ELISA and PCR, which has higher specificity and sensitivity, but these modalities are usually complex, lengthy and costly. Moreover, for the detection of Ns1, IgG and IgM, separate methods/tests are used. It is a most challenging task to diagnose infection with the dengue virus in the initial stages of dengue attack, essential to prevent a pandemic, and for recovery of the patient. Where rapid detection is required, compromise has to be made on specificity and sensitivity.
Raman spectroscopy has been proven in recent years to be a highly sensitive and specific technique for the definition of biomedical changes produced in the body and diagnosis of different diseases [17] [18] . It has been extensively employed over the past two decades for the characterisation of biological cells and tissue [19] and the influence of external agents on the cell [20] [21] [22] [23] [24] [25] . Moreover, Raman spectroscopy has the capability to provide high content information, and even small changes in any of the biological macromolecules, including lipids, proteins and DNA, can be characterised simultaneously [26] [27] [28] . The Raman spectral changes which are identified could be helpful as diagnostic markers for the disease.
Recently, viral infections such as human papilloma (HPV), Hepatitis C (HCV), dengue virus and many other diseases have been successfully monitored by Raman spectroscopy [29] [30] [31] [32] . Khan et al. demonstrated the potential of Raman spectroscopy, coupled with support vector machine analysis, to diagnose dengue infection in human serum, based on positive IgM status, with a high degree of accuracy (85%) and precision (90%), and corresponding sensitivity and specificity of 73% and 93%, respectively [33] . Bilal et al. performed a similar analysis, based on Partial Least Squares Regression analysis of Raman spectroscopic data of IgM positive and normal human serum samples, and using the receiver operating characteristic curve (ROC) approach, reported an accuracy of 96.67%, a sensitivity of 90% and a specificity of 100% [34] . However, in both studies, spectroscopic data was correlated with only one of the three common clinical biomarkers.
In the present study, correlations between the levels Ns1, IgG and IgM positive blood plasma samples as measured using conventional ELISA kits, are compared and it is observed that there are few or no correlations. Raman spectroscopy, coupled with Principal Components Analysis (PCA) is explored for differentiation between normal/healthy and Ns1, IgG and IgM positive blood plasma samples, which could pave the path for a more comprehensive monitoring of the stage of the infection by establishing specific Raman spectral features associated with these three markers of the disease. A combination of PCA and Factorial Discriminant Analysis (PCA-FDA) is employed to quantify the diagnostic potential of the technique.
Materials and methods

Sample preparation
Blood plasma samples of 17 control (healthy volunteers) and 17 patients who presented with symptoms of dengue infection, were collected from Allied Hospital Faisalabad, Pakistan. All the blood plasma samples were handled according to the US NIH (National Institute of Health) recommendations. Quantitative serology of the 17 patient samples was performed to measure the levels of NS1 protein, IgG and IgM by using ELISA kits for dengue (Vircell Cat No. G1018, M1018). The outputs of the test kits are expressed in terms of optical density, and for this study, the cut off values for Ns1, IgM and IgG were 0.389, 0.378 and 0.384 respectively, as prescribed by the manual for the respective kits. In this regard, it is important to mention that these cut off values for the Ns1, IgM and IgG can be found only for the dengue infected patients and not for the healthy/control samples, as all the three biomarkers are associated specifically with the infection of the virus. The different values of Ns1, IgM and IgG, are shown in Table 1 , along with their categorisation according to Normal, Medium and High levels of biomarker.
Raman spectral acquisition
To minimise any effects of heating due to residual absorbance in plasma at the laser wavelength of 785nm, a 20 μl drop of each plasma sample was placed on an aluminium slide at room temperature and Raman spectra were acquired before the plasma sample had dried. The process of placing the 20μl drop on the aluminium slide was repeated 3 times by employing a clean aluminium slide each time for acquiring 20-25 spectra in total from each sample.
Raman spectral acquisition from all of the 17 healthy control and 17dengue infected blood plasma samples was performed using a Raman spectrometer (Peak Seeker Pro-785; Agiltron, USA). The Peak Seeker Pro-785 utilizes a 785nm diode laser as the excitation source, delivering a laser power of ~60 mW at the sample. The laser was delivered to the sample through a 10× objective. The acquisition of the Raman spectra for all the samples was executed from 600 to 1800 cm -1 and 20-25 Raman spectra per sample were acquired with an acquisition time of 30 second. Table 1 : Details of dengue samples and their different serologically determined values of the biomarkers Ns1, IgM and IgG. Numbers in (brackets) define the clinical cut off between normal and infected. For the purpose of this study, the latter categories are further differentiated according to "Medium" and "High" biomarker levels.
Data pre-processing
All data processing of the Raman spectra was performed using MatLab 7.8 and established protocols [26] . Data pre-processing included baseline correction, smoothing, vector normalisation, and substrate removal. All spectra, including substrate backgrounds, were vector normalised and smoothed using a Savitzky-Golay smoothing method (order 3, 17 point window). A rubber band correction for baseline removal for all the spectra was carried out and the substrate spectra were subtracted from each spectrum.
Data analysis
The Raman spectral features were analysed by comparing the mean Raman spectra of dengue infected blood plasma samples with healthy ones. The assignments of the Raman spectral features used in interpretation of the results were taken from the literature [25, [35] [36] [37] [38] and are described in PCA was employed in this study to highlight the variability existing in the spectral data set recorded for the different tests of the dengue infection, and to differentiate their spectroscopic signatures. PCA-FDA was employed to further discriminate spectra based on the levels of the markers of dengue infection, such as IgG, demonstrating the diagnostic potential of the technique.
Supervised learning methods such as discriminant analyses enable classification of unknown samples using prior knowledge of the category from training sets. To predict the qualitative affiliation of data points to a defined group (for instance level of the dengue antibody IgG), the coupling of PCA with Factorial Discriminant Analysis (PCA-FDA) exploits the calculated PC scores to better evaluate the discrimination rate achieved based on a data set [39] .In the present study, leave one patient out strategy has been employed to discriminate between healthy and dengue blood plasma. The classification values obtained for each iteration have been gathered to deliver an overall confusion matrix representative of the data discrimination. For this type of strategy, the model is restricted to a specified number of iteration, dictated by the number of patients. In present study, there are 34 groups of spectra (17 healthy and 17 dengue). Thus, in each iteration, one is patient taken out as validation and the 33 remaining are used as calibration.
Peak cm -1 Assignment 608
Cholesterol 656
Protiens(L-histidine) 688
Glycine 708
Tryptophan 802
Uracil-based ring breathing mode 828
Proline, hydroxyproline, tyrosine, v2PO2stretch of nucleic acids 849
Most probably due to single-bond stretching vibration for the amino acids and valine and polysaccharides. Also assigned to proline, tyrosine, tryptophan-IgG 875
Antisymmetric stretch vibration of choline group N + ( Figure 1 plots the ELISA based serology results of all three biomarkers for all samples, demonstrating that there is no clear correlation between the relative levels of the different biomarkers across the sample set. As can also be seen from Table 1 , there are many instances of high levels of one biomarker, and normal levels of one or both of the other two. The serology biomarkers are therefore not an unambiguous diagnostic test for the presence of dengue infection. IgG is detectable after one week to several months [40] [41] [42] . Figure 2 shows the mean Raman spectra of the healthy (control) and dengue infected blood plasma samples. The major differences in the Raman spectral features are labelled as vertical lines, and are assigned in Table 2 . These spectral features can be considered as Raman spectral markers of biochemical changes associated with the dengue infection. Increases are seen in bands associated with the lipidic contents including 608cm -1 , 875cm -1 , 1297cm -1 , 1719 cm -1 and 1736 cm -1 . Notably, in the literature [38] these bands are associated specifically as cholesterol (608cm -1 ), choline (875cm -1 ), palmitic acid (1297cm -1 ), glutamic acid (1719 cm -1 ) and ester groups (1736 cm -1 ),
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indicating an increase in lipidic content in dengue infected samples. The lipids provide sites for the virus to attach, and hence a high concentration of lipids in dengue infected blood plasma can be associated with the dengue infection [43] . Furthermore, the complement-fixing of antibodies IgM is greater for higher amount of cholesterol and the Raman feature at 608 cm -1 is consistent with a high concentration of cholesterol (lipids) in the Raman spectra of dengue samples, so this peak may be associated with the greater complement fixing of the IgM and hence development of the dengue disease [44] .
Raman spectral features associated with proteins are also observed as prominent differentiating factors. The peak intensity of the feature at 1239 cm -1 (amide III (CH2 wagging vibration)) is greater in the mean Raman spectra of dengue infected blood plasma. This has previously been associated with IgM [45] . There is also an increase in the intensity at 1409 cm -1 in dengue infected samples which can be associated with the IgG antibody (IgG (vsCOO -1 ). The Raman spectral features at "608 (lipids), 688 (glycine), 708 (tryptophan), 1164 (C-H bending), 1297 (lipids), 1507 (protein A), 1640 and 1680 (amide-I) and 1719 cm-1 (lipids) are observed with significantly higher intensities in dengue positive samples as compared to dengue negative samples/healthy ones and are also associated with proteins. Notably, although the samples were measured in their wet state, the characteristic, but weak, water feature at ~1640cm-1 is not apparent in the spectrum of the control.
Other spectral features associated with proteins include those at 880(tryptophan), 656(L-histidine) and 1164(tyrosine), 1102(amide III of proteins), 1343(CH3, CH2 wagging), 1587(haemoglobin) and 1317 cm -1 (C-H deformation), and have higher intensity in dengue infected blood plasma samples than in healthy volunteers.
Notably, the Raman spectral features at 828 and 849cm -1 , associated with out of plane tyrosine ring breathing [46] , have higher intensity in the mean Raman spectra of healthy than dengue infected samples. A small peak evident with higher intensity in dengue infected spectra at 1491 cm -1 is due the C-N stretching vibration coupled with the in plane C-H bending in amino radical cations. The peak at 1507 cm -1 , again present with significantly higher intensity in the mean Raman spectra of dengue infected blood plasma, is due to N-H bending and has been reported for lysine present in protein A [47] , which strongly binds IgG and makes variable binding with IgM [48] .
The small peak at 1540 cm -1 which is significant in the dengue infected blood plasma is the Raman feature of the amide carbonyl group vibration and aromatic hydrogen and it has been reported that this peak is associated with the non structural protein (Ns1) [49] . The prominence of proteins in the Raman spectral data of dengue infected blood plasma can therefore be associated with the presence of dengue virus. In order to quantify the diagnostic potential of the spectroscopic technique, a further classification of the control and dengue groups using PCA-FDA was carried out. The results are shown in Table   3 , which indicates that, based on the spectroscopic analysis of the current, albeit limited, cohort of samples, Principal Components Analysis (PCA) coupled with Factorial Discriminant Analysis, values of 97.95% sensitivity and 95.40% specificity for identification of dengue infection can be achieved., which is comparable with the sensitivity of 98% and specificity of 100% of dengue kit, as quoted on the dengue-kit used for the current study (Vircell Cat No. G1018, M1018).
Notably, however, each test needs to be performed separately and independently for each sample, and is thus more demanding on consumables and therefore cost, whereas the Raman assay is label free, and simply requires the plasma from the blood of the dengue patients. Table 4 : Results of the PCA-FDA for the Raman spectral data of Normal versus all lows mixed (Ns1,IgM and IgG) samples.
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Conclusions:
The potential of Raman spectroscopy for the diagnosis and characterisation of healthy and dengue infected human blood plasma samples has been demonstrated. The spectral analysis indicates that distinct Raman spectral features are observed in the dengue positive samples, potentially associated with the development of the disease, as compared to the healthy samples. These Raman spectral features hence can be considered as markers of the dengue development and can be helpful for the diagnosis of the disease. Multivariate analysis with PCA and PCA-FDA enables a more precise identification of these spectral markers, and also allows a quantification of the diagnostic potential. Notably, as the Raman analysis is not based specifically on an individual biomarker, it provides a more holistic view of the biochemical content of the sample, and abnormalities associated with the disease. Critically, it identifies the presence of the disease in samples for which at least one of the biomarker tests indicated low levels, and thus can be considered an alternative for improved, unambiguous screening.
